Assistant Clinical Professor
Primary Care Physician
To see if Olivia Marie Campa is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
I am dedicated to delivering high-quality, compassionate care to people in the Sacramento community. My clinical, academic and research endeavors focus on finding ways to connect with patients and provide treatment for their physical concerns and more, an approach known as “whole person” care.
Dr. Campa believes in providing holistic and comprehensive primary care. She specializes in medication assisted treatment (MAT) for opioid use disorder, transgender care including management of hormone therapy, women’s health care including Nexplanon placement and removal, integrative mental health care with primary care, HIV pre-exposure prophylaxis (PrEP), and teaching medical students and Internal Medicine residents.
Dr. Campa's research interest focus on diversity and inclusion and interprofessional communication in the healthcare setting.
B.S., Natural Sciences, Loyola Marymount University, Los Angeles CA 2006
M.D., UC Davis, Sacramento CA 2014
Internal Medicine, UC Davis, Sacramento CA 2014-2015
Internal Medicine, UC Davis, Sacramento CA 2015-2017
Ambulatory Chief Resident, UC Davis, Sacramento CA 2017-2018
National Medical Fellowship (NMF) Community Health Award, 2018
Alpha Omega Alpha Honor Medical Society (AΩA), 2017
Gold Humanism Honor Society Member, 2017
Excellence in Medicine Award, American Medical Association Foundation, 2012
Herbert W. Nickens Medical Student Scholarship, Association of American Medical Colleges, 2012
For a comprehensive list of Dr. Campa's publications, please click here.
National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. doi:10.1056/NEJMoa1102873. Epub 2011 Jun 29. PMID: 21714641.
National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ. The National Lung Screening Trial: overview and study design. Radiology. 2011 Jan;258(1):243-53. doi:10.1148/radiol.10091808. Epub 2010 Nov 2. PMID:21045183.
Daly KA, Campa OM. Reducing jail recidivism for women with co-occurring disorders. Psychiatr Serv. 2014 Jan 1;65(1):130. doi:10.1176/appi.ps.641111. PMID:24382768.
Sultzer DL, Melrose RJ, Harwood DG, Campa O, Mandelkern MA. Effect of memantine treatment on regional cortical metabolism in Alzheimer's disease. Am J Geriatr Psychiatry. 2010 Jul;18(7):606-14. doi:10.1097/JGP.0b013e3181ca3a4e. PMID:20220580.
Woo BK, Harwood DG, Melrose RJ, Mandelkern MA, Campa OM, Walston A, Sultzer DL. Executive deficits and regional brain metabolism in Alzheimer's disease. Int J Geriatr Psychiatry. 2010 Nov;25(11):1150-8. doi:10.1002/gps.2452. PMID:20069587.
Melrose RJ, Ettenhofer ML, Harwood D, Achamallah N, Campa O, Mandelkern M, Sultzer DL. Cerebral metabolism, cognition, and functional abilities in Alzheimer disease. J Geriatr Psychiatry Neurol. 2011 Sep;24(3):127-34. doi:10.1177/0891988711405333. PMID:21856969.
Melrose RJ, Campa OM, Harwood DG, Osato S, Mandelkern MA, Sultzer DL. The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG-PET study. Int J Geriatr Psychiatry. 2009 Aug;24(8):885-93. doi:10.1002/gps.2229. PMID:19296551.
Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013 Sep 5;369(10):920-31. doi:10.1056/NEJMoa1208962. PMID:24004119.